EE200200517A - Monoklonaalne antikeha, selle valmistamine ning kasutamine inimese madala tihedusega lipoproteiinide retseptori (LDLR) tuvastamiseks ja puhastamiseks - Google Patents

Monoklonaalne antikeha, selle valmistamine ning kasutamine inimese madala tihedusega lipoproteiinide retseptori (LDLR) tuvastamiseks ja puhastamiseks

Info

Publication number
EE200200517A
EE200200517A EEP200200517A EEP200200517A EE200200517A EE 200200517 A EE200200517 A EE 200200517A EE P200200517 A EEP200200517 A EE P200200517A EE P200200517 A EEP200200517 A EE P200200517A EE 200200517 A EE200200517 A EE 200200517A
Authority
EE
Estonia
Prior art keywords
ldlr
purification
preparation
detection
monoclonal antibody
Prior art date
Application number
EEP200200517A
Other languages
English (en)
Estonian (et)
Inventor
Yonah Nachum
Suissa Dany
Belzer Ilana
Antonetti Francesco
Smolarsky Moshe
Dreano Michel
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26323933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200200517(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL13502500A external-priority patent/IL135025A0/xx
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of EE200200517A publication Critical patent/EE200200517A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP200200517A 2000-03-13 2001-03-08 Monoklonaalne antikeha, selle valmistamine ning kasutamine inimese madala tihedusega lipoproteiinide retseptori (LDLR) tuvastamiseks ja puhastamiseks EE200200517A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13502500A IL135025A0 (en) 2000-03-13 2000-03-13 Monoclonal antibodies to the human ldl receptor, their production and use
IL13921700A IL139217A0 (en) 2000-03-13 2000-10-23 Monoclonal antibodies to the human ldl receptor, their production and use
PCT/IL2001/000216 WO2001068710A1 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use

Publications (1)

Publication Number Publication Date
EE200200517A true EE200200517A (et) 2004-02-16

Family

ID=26323933

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200517A EE200200517A (et) 2000-03-13 2001-03-08 Monoklonaalne antikeha, selle valmistamine ning kasutamine inimese madala tihedusega lipoproteiinide retseptori (LDLR) tuvastamiseks ja puhastamiseks

Country Status (32)

Country Link
US (1) US6849720B2 (de)
EP (1) EP1263790B1 (de)
JP (1) JP4768193B2 (de)
KR (1) KR100882081B1 (de)
CN (1) CN1418225B (de)
AR (1) AR028518A1 (de)
AT (1) ATE362490T1 (de)
AU (2) AU2001241002B8 (de)
BG (1) BG65762B1 (de)
BR (1) BR0109164A (de)
CA (1) CA2402593C (de)
CY (1) CY1108020T1 (de)
CZ (1) CZ20023098A3 (de)
DE (1) DE60128452T2 (de)
DK (1) DK1263790T3 (de)
EA (1) EA007494B1 (de)
EE (1) EE200200517A (de)
ES (1) ES2282238T3 (de)
HR (1) HRP20020704B1 (de)
HU (1) HU226194B1 (de)
IL (2) IL139217A0 (de)
MX (1) MXPA02009091A (de)
NO (1) NO330904B1 (de)
NZ (1) NZ520944A (de)
PL (1) PL206041B1 (de)
PT (1) PT1263790E (de)
RS (1) RS51406B (de)
SI (1) SI1263790T1 (de)
SK (1) SK287348B6 (de)
UA (1) UA78489C2 (de)
WO (1) WO2001068710A1 (de)
ZA (1) ZA200206654B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114629D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Method
WO2004111652A1 (en) 2003-06-19 2004-12-23 Applied Research Systems Ars Holding N.V. Use of prion conversion modulating agents
FR2889533B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
FR2889532B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
EP1991869A2 (de) * 2006-02-17 2008-11-19 Paolo La Colla Verfahren zur diagnose von proliferations- und/oder konformationskrankheiten
FR2910896B1 (fr) * 2006-12-29 2012-11-16 Lab Francais Du Fractionnement Anticorps monoclonal dirige contre le recepteur humain des ldl
IL182956A0 (en) 2007-05-03 2008-01-20 Yeda Res & Dev Glycan modified soluble receptors and binding proteins and their use
IL188628A0 (en) * 2008-01-07 2008-12-29 Yeda Res & Dev Use of soluble ldl-r for viral hepatitis
GB0922377D0 (en) * 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
US20130129676A1 (en) 2010-05-25 2013-05-23 Universite De Strasbourg Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
WO2013024155A1 (en) 2011-08-17 2013-02-21 Inserm (Institut National De La Sante Et De La Recherche Medicale) Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection
WO2013024157A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of host targeting agents for the treatment and the prevention of hcv infection
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
CN103111270B (zh) * 2013-02-26 2015-06-10 王业富 一种乙型肝炎抗原蛋白的吸附材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182364A (en) * 1990-02-26 1993-01-26 The Scripps Research Institute Polypeptide analogs of apolipoprotein E
US5496926A (en) * 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
US5945308A (en) * 1998-04-03 1999-08-31 Incyte Pharmaceuticals, Inc. Human oxidized LDL receptor
JP2000279174A (ja) * 1999-03-30 2000-10-10 Bml Inc ヒトｌｄｌレセプターに対するモノクローナル抗体及びこれを用いる家族性高脂血症の判定方法

Also Published As

Publication number Publication date
HUP0300142A2 (hu) 2003-06-28
EP1263790B1 (de) 2007-05-16
AR028518A1 (es) 2003-05-14
CN1418225A (zh) 2003-05-14
DK1263790T3 (da) 2007-07-02
US6849720B2 (en) 2005-02-01
KR20020089384A (ko) 2002-11-29
IL151713A0 (en) 2003-04-10
DE60128452T2 (de) 2007-09-13
PT1263790E (pt) 2007-06-01
YU68602A (sh) 2006-03-03
SK13122002A3 (sk) 2003-04-01
CA2402593A1 (en) 2001-09-20
IL139217A0 (en) 2001-11-25
AU2001241002B2 (en) 2006-04-06
NZ520944A (en) 2004-04-30
DE60128452D1 (de) 2007-06-28
HUP0300142A3 (en) 2005-07-28
PL358381A1 (en) 2004-08-09
KR100882081B1 (ko) 2009-02-10
BR0109164A (pt) 2002-11-26
BG65762B1 (bg) 2009-10-30
NO20024223D0 (no) 2002-09-04
UA78489C2 (en) 2007-04-10
CN1418225B (zh) 2012-04-18
EA007494B1 (ru) 2006-10-27
NO20024223L (no) 2002-10-24
NO330904B1 (no) 2011-08-15
HRP20020704A2 (en) 2004-12-31
HK1055750A1 (en) 2004-01-21
PL206041B1 (pl) 2010-06-30
HRP20020704B1 (en) 2011-01-31
ES2282238T3 (es) 2007-10-16
MXPA02009091A (es) 2005-06-20
EP1263790A1 (de) 2002-12-11
JP2004506603A (ja) 2004-03-04
WO2001068710A1 (en) 2001-09-20
BG107063A (bg) 2003-05-30
US20030186343A1 (en) 2003-10-02
CZ20023098A3 (cs) 2003-02-12
EA200200974A1 (ru) 2003-02-27
CY1108020T1 (el) 2013-09-04
HU226194B1 (hu) 2008-06-30
JP4768193B2 (ja) 2011-09-07
ATE362490T1 (de) 2007-06-15
SI1263790T1 (sl) 2007-10-31
AU4100201A (en) 2001-09-24
ZA200206654B (en) 2003-10-20
AU2001241002B8 (en) 2006-05-04
RS51406B (sr) 2011-02-28
SK287348B6 (sk) 2010-08-09
CA2402593C (en) 2012-07-03

Similar Documents

Publication Publication Date Title
CY2019022I2 (el) Ανθρωπινα cdr-μοσχευμενα αντισωματα και θραυσματα αντισωματων τους
EE200200517A (et) Monoklonaalne antikeha, selle valmistamine ning kasutamine inimese madala tihedusega lipoproteiinide retseptori (LDLR) tuvastamiseks ja puhastamiseks
CY2019029I1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
AR027976A1 (es) Anticuerpos humanos para cd154
EP1423431A4 (de) Antikörper gegen vla-1
AU2002351239A8 (en) Antibody to latent membrane proteins and uses thereof
BR0115124B1 (pt) dispositivo para fundir uma amostra hiperpolarizada sàlida, mÉtodo para produzir uma amostra hiperpolarizada fundida, e, uso de um dispositivo ou mÉtodo.
NO20030443D0 (no) Fremgangsmåte for fremstilling av funksjonelle proteindomener
DE60222658D1 (de) Monoklonaler anti-cd-40-antikörper
NO20033387D0 (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
EE200000470A (et) Inimese CD40-vastased antikehad
NO20031642D0 (no) Humaniserte anti-LT-O-R-antistoff
DE60142792D1 (de) Testvorrichtung zur bestimmung von hdl(high density lipoprotein)-cholesterin
BR0110968A (pt) Antagonistas dos receptores de il-8
NO20032542L (no) Dempede anti-CD28-antistoffer og anvendelse derav
EE200300400A (et) Pürimidiiniühendid, nende valmistamismeetod ning kasutamine
DE60108043D1 (de) Zerstörungsfreies Inspektionsverfahren
EP1680666A4 (de) Nachweisen von menschlichen antitherapeutischen antikörpern
DK1164375T3 (da) Assay til antitransglutaminaseantistoffer
EP1178829A4 (de) Menschlicher monoklonaler antikörper
DE60045870D1 (de) Monoklonaler antikörper, hybridoma, immuntestverfahren und diagnosekit
EP1272205A4 (de) SIALOADHESIN FAKTOR-2 ANTIKöRPER
NO20030201D0 (no) Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner
ITPD20000192A0 (it) Anticorpi policlonali
IT1305309B1 (it) Procedimento per la purificazione di anticorpi anti-tireoglobulina eusi di detti anticorpi.

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
HC1A Change of owner name